A diverse team with a unique mix of experience and talent.
Composed of a leadership team with over a century of experience bringing successful new technologies to market (with decades in MedTech and software), along with world-class neuroscience researchers and machine learning engineers, the Senseye team is balanced for the mission at hand.
And we’re not on the journey alone. Our Medical Advisory Board is made up of the brightest and most experienced minds in PTSD research & treatment.
Leadership Team
David Zakariaie
CEO & Founder
David is the CEO and Founder of Senseye. In 2012, Google selected him as one of 100 Google Glass Pioneers. He is also the recipient of an Office of Naval Research Award for research in DNA Computing. When not in the lab, he is an Instructor Pilot & Check Airman in the Civil Air Patrol.
Kathleen
SVP of Product
Kathleen Bauman is the Senior Vice President of Product at Senseye. Kathleen brings a wealth of experience in product development, including product management, product design, and program management roles. She has over twenty years experience in the software industry with the majority of that time spent working on software as a medical device (SaMD) products, as regulated by the FDA.
Allison Fabian
Chief of Staff, Head of Community Outreach
Allison has over 15 years of experience as a strategic leader dedicated to driving growth and impact. Previously, she worked in business development and operations at Sony and RE/MAX. A longtime advocate for mental health, Allison serves on the board of NAMI NYC, championing initiatives that support accessibility, awareness, and innovation in mental healthcare.
David Durrant
SVP of Development | Senseye
David is a seasoned technology leader with deep expertise in software development, object-oriented technologies, and web technologies. With a career spanning telecommunications, commodity trading, and healthcare, he has successfully led large global development teams and driven technical innovation across multiple industries.Throughout his career, David has played a pivotal role in guiding organizations through agile transformations, optimizing development processes, and managing complex compute infrastructures—both physical and virtual. His leadership extends to the machine learning space, where he has overseen the staff developing cutting-edge AI solutions and architecting scalable, high-performance environments for model training and deployment.With a strong focus on innovation
and mentorship, David is committed to fostering talent and enabling teams to excel in fast-paced, technology-driven environments. At Senseye, he continues to shape the future of software, AI, and infrastructure, ensuring that the company remains at the forefront of technological advancement.
Brad Strasser
VP of Clinical, Quality & Regulatory
Brad brings over 16 years experience working in the medical device industry. He has served in clinical, quality, and regulatory affairs capacities at both large corporations and small startups, helping secure Class I, Class II, and Class III device clearances and approvals through FDA, EU Notified Bodies, and other regulatory agencies around the world.
Caitlin Limonciello, PhD
Director of Research
Caitlin earned her doctorate studying visual short-term memory and applying predictive models to the understanding of these memory processes. She then went on to a postdoctoral fellowship to study the neural mechanisms of 3D vision. She has 17 years of experience in human subjects experimental research and statistical analysis.
Medical Advisory Board
Charles Nemeroff, MD, PhD
Chairperson
Dr. Nemeroff has for decades been one of the leading figures in American trauma research and practice. As Professor and Chair Dept. of Psychiatry at the Mulva Clinic & Director Dell Medical School, UT Austin, in addition to his role as President of the Anxiety and Depression Association of America he is intensely interested in the role technology can play in improving patient outcomes.
Barbara Rothbaum, PhD, ABPP
Dr. Rothbaum is Director of the Emory Healthcare Veterans Program and professor and Associate Vice Chair of Clinical Research at Emory School of Medicine in the Department of Psychiatry and Behavioral Sciences and Director of the Trauma and Anxiety Recovery Program and holds the Paul A. Janssen Chair in Neuropsychopharmcology. She specializes in research on the treatment of anxiety disorders, particularly PTSD. Dr. Rothbaum has been studying PTSD treatments since 1986 and has developed, tested, and disseminated some of the most innovative and effective treatments available for PTSD.
Steven Berkowitz, MD
Dr. Berkowitz is a leading researcher & practitioner in child & family trauma interventions. He will leverage his extensive knowledge of PTSD symptomatology, predispositions for adult onset of PTSD, and concomitant contributing medical conditions and treatment interactions to guide Senseye on signal utility.
Dr. Ressler, Chief scientific officer
Dr. Ressler is Chief scientific officer and James and Patricia Poitras Chair in Psychiatry at McLean Hospital and professor in psychiatry at Harvard Medical School. His work focuses on translational research that bridges basic studies of the mechanisms of fear in animal models with clinical research on the genetics that underlie human fear and anxiety disorders, particularly post-traumatic stress disorder (PTSD).
CONNECT